Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 4:5:211-6.
doi: 10.1016/j.ebiom.2016.01.030. eCollection 2016 Mar.

Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?

Saumya Shekhar Jamuar  1 , Jyn Ling Kuan  2 , Maggie Brett  3 , Zenia Tiang  2 , Wilson Lek Wen Tan  2 , Jiin Ying Lim  4 , Wendy Kein Meng Liew  1 , Asif Javed  5 , Woei Kang Liew  4 , Hai Yang Law  1 , Ee Shien Tan  1 , Angeline Lai  1 , Ivy Ng  1 , Yik Ying Teo  6 , Byrappa Venkatesh  7 , Bruno Reversade  8 , Ene Choo Tan  3 , Roger Foo  2
Affiliations

Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?

Saumya Shekhar Jamuar et al. EBioMedicine. .

Abstract

Background: In Western cohorts, the prevalence of incidental findings (IFs) or incidentalome, referring to variants in genes that are unrelated to the patient's primary condition, is between 0.86% and 8.8%. However, data on prevalence and type of IFs in Asian population is lacking.

Methods: In 2 cohorts of individuals with genomic sequencing performed in Singapore (total n = 377), we extracted and annotated variants in the 56 ACMG-recommended genes and filtered these variants based on the level of pathogenicity. We then analyzed the precise distribution of IFs, class of genes, related medical conditions, and potential clinical impact.

Results: We found a total of 41,607 variants in the 56 genes in our cohort of 377 individuals. After filtering for rare and coding variants, we identified 14 potential variants. After reviewing primary literature, only 4 out of the 14 variants were classified to be pathogenic, while an additional two variants were classified as likely pathogenic. Overall, the cumulative prevalence of IFs (pathogenic and likely pathogenic variants) in our cohort was 1.6%.

Conclusion: The cumulative prevalence of IFs through genomic sequencing is low and the incidentalome may not be a significant barrier to implementation of genomics for personalized medicine.

Keywords: Genomic sequencing; Incidental findings; Personalized medicine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Filtering strategy.
See this image and copyright information in PMC

References

    1. Adzhubei I., Jordan D.M., Sunyaev S.R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013 (Chapter 7: Unit7 20) - PMC - PubMed
    1. Amendola L.M., Dorschner M.O., Robertson P.D., Salama J.S., Hart R., Shirts B.H. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015;25(3):305–315. - PMC - PubMed
    1. Ayuso C., Millan J.M., Dal-Re R. Management and return of incidental genomic findings in clinical trials. Pharmacogenomics J. 2015;15(1):1–5. - PubMed
    1. Ballinger M.L., Mitchell G., Thomas D.M. Surveillance recommendations for patients with germline TP53 mutations. Curr. Opin. Oncol. 2015;27(4):332–337. - PubMed
    1. Berg J.S., Khoury M.J., Evans J.P. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet. Med. 2011;13(6):499–504. - PubMed

LinkOut - more resources